Market Access
Potential Policy Changes that Could Upend Prescription Drug Pricing
On November 3, 2021, Congress introduced a working draft of the Build Back Better ...
Roadmap to Improved Coverage and Access for Specialty Products
As specialty pharmaceutical products are becoming increasingly complex due to more technology-driven drug development, ...
Improving Your Patient Support Programs for Expanded Affordability
Patient support programs (PSPs), patient assistant programs (PAPs), copay coupons, or whatever name you ...
Establishing a Successful Pharma-Payer Relationship in 2022
If a life sciences company wants to start their relationship with a payer off ...
Two Key Questions About Payer Strategies in 2022
PM360 asked experts in dealing with payers to tell us the optimal strategies for ...
The Economic Burden of Rare Diseases and Need for Improved Policy
Rare diseases represent a major societal issue with significant costs. An estimated 400 million ...
Numbers Don’t Lie: Healthcare Consumerism Takes Center Stage
A lot of big, unwieldy trends are impacting today’s $4 trillion healthcare landscape as ...
Alzheimer’s Sea Change: Primary Care Doctors and Market Access
Treatment advances for Alzheimer’s disease took a quantum leap last year. As of early ...
Top Takeaways from the 2021 Coupon and Copay Forum
At CBI’s ninth annual Coupon & Copay Forum in October, industry experts gathered both ...
Payer Perceptions and Trends of Real-World Evidence in Oncology
In the evolving field of oncology drug development, clinical and financial insights can be ...
Navigating the Payer Landscape for Digital Therapeutics
Over the last several years, significant investments in digital health and technology solutions have ...
How Competition Affects Market Access for Rare Disease Therapeutics
For years, the rare disease community has looked forward to a time when patients ...
Impact of COVID-19 Pandemic on Funding and Reimbursement of Pharmaceuticals and Vaccines
Most European countries have experienced more than one wave of COVID-19 infections. Lockdown and ...
